Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
group | 0.500 | None | 0.975 | 40 | 13 | 1987 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.370 | None | 1.000 | 40 | 0 | 1988 | 2015 | ||||||||
|
myelin protein zero | 0.503 | 0.846 | 0.27 |
|
disease | 1.000 | None | 1.000 | 39 | 51 | 1992 | 2019 | ||||||||
|
collagen type I alpha 1 chain | 0.430 | 0.808 | 1.00 |
|
disease | 0.890 | None | 1.000 | 38 | 61 | 1986 | 2019 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
disease | 1.000 | None | 0.982 | 37 | 677 | 1953 | 2020 | ||||||||
|
parkin RBR E3 ubiquitin protein ligase | 0.431 | 0.846 | 6.9E-07 |
|
disease | 1.000 | None | 0.994 | 37 | 28 | 1998 | 2019 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 1.000 | None | 0.961 | 36 | 98 | 1972 | 2019 | ||||||||
|
amyloid beta precursor protein | 0.422 | 0.846 | 4.7E-02 |
|
disease | 0.400 | None | 0.981 | 35 | 0 | 1991 | 2020 | ||||||||
|
amyloid beta precursor protein | 0.422 | 0.846 | 4.7E-02 |
|
disease | 0.400 | None | 0.993 | 35 | 0 | 1988 | 2019 | ||||||||
|
amyloid beta precursor protein | 0.422 | 0.846 | 4.7E-02 |
|
disease | 0.400 | None | 0.986 | 35 | 0 | 1991 | 2019 | ||||||||
|
amyloid beta precursor protein | 0.422 | 0.846 | 4.7E-02 |
|
disease | 0.300 | None | 1.000 | 35 | 0 | 1991 | 2018 | ||||||||
|
amyloid beta precursor protein | 0.422 | 0.846 | 4.7E-02 |
|
disease | 0.300 | None | 1.000 | 35 | 0 | 1991 | 2018 | ||||||||
|
amyloid beta precursor protein | 0.422 | 0.846 | 4.7E-02 |
|
disease | 0.500 | None | 0.984 | 35 | 1 | 1991 | 2020 | ||||||||
|
alkaline phosphatase, biomineralization associated | 0.546 | 0.769 | 3.6E-04 |
|
disease | 0.950 | None | 0.975 | 33 | 54 | 1988 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.600 | None | 0.974 | 33 | 0 | 1991 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.700 | None | 0.974 | 33 | 1 | 1990 | 2020 | ||||||||
|
plasminogen activator, tissue type | 0.445 | 0.885 | 5.7E-05 |
|
disease | 0.400 | None | 0.978 | 33 | 0 | 1986 | 2019 | ||||||||
|
potassium voltage-gated channel subfamily H member 2 | 0.522 | 0.731 | 1.00 |
|
disease | 0.800 | None | 0.989 | 32 | 259 | 1995 | 2019 | ||||||||
|
ryanodine receptor 1 | 0.489 | 0.808 | 1.6E-29 |
|
disease | 1.000 | None | 1.000 | 32 | 101 | 1993 | 2019 | ||||||||
|
sodium voltage-gated channel alpha subunit 1 | 0.477 | 0.808 | 1.00 |
|
disease | 0.730 | None | 1.000 | 32 | 58 | 2000 | 2012 | ||||||||
|
calcium sensing receptor | 0.410 | 0.846 | 4.7E-02 |
|
disease | 1.000 | None | 0.993 | 32 | 42 | 1976 | 2020 | ||||||||
|
hexosaminidase subunit alpha | 0.633 | 0.615 | 1.3E-11 |
|
disease | 1.000 | None | 1.000 | 31 | 118 | 1982 | 2019 | ||||||||
|
butyrylcholinesterase | 0.447 | 0.923 | 1.1E-13 |
|
phenotype | 0.400 | None | 1.000 | 31 | 0 | 1967 | 2018 | ||||||||
|
glial fibrillary acidic protein | 0.421 | 0.885 | 1.5E-06 |
|
disease | 1.000 | None | 0.972 | 30 | 90 | 1976 | 2020 | ||||||||
|
protoporphyrinogen oxidase | 0.678 | 0.500 | 2.8E-02 |
|
disease | 0.900 | None | 1.000 | 30 | 21 | 1981 | 2019 |